Recent Appointment

CEO and R&D Director

Tim Sparey & Andrew Ratcliffe

Bailey Fisher Executive Search is pleased to have worked with early stage oncology therapeutics company, Novintum Bioscience, to appoint a CEO and R&D Director.

Bailey Fisher Executive Search was engaged by Rising Tide, a US/Swiss fund, to manage the search for a CEO for Novintum Bioscience, one of their portfolio companies.  The search resulted in the appointment of Tim Sparey, an experienced pharmaceutical professional with a background in blue chip, large and specialty pharma, as well as earlier stage biotech companies.

Following Tim’s appointment as CEO, Bailey Fisher was re-engaged by Novintum Bioscience to lead the search for an experienced “drug hunter” as R&D Director, to work alongside the CSO as a senior executive leader in the organisation.  The search resulted in the appointment of Andrew Ratcliffe, an internationally experienced and highly motivated R&D Director.

 

 

 

❰ Back

This search was managed by 

James Houlder

Partner & Director of Research

DD: +44 (0)1223 422433
M: +44 (0)7803 520855